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A B S T R A C T
Muscle fibers are dynamic structures capable of altering their phenotype under various pathological conditions. The
aim of the present study was to investigate the influence of long-lasting diabetes mellitus on the process of muscle regen-
eration in the skeletal muscle. Wistar rats were made diabetic by a single intraperitoneal injection of streptozotocin
(STZ). The regeneration process in the skeletal muscle was induced in slow (m. soleus, SOL) and fast (m. extensor
digitorum longus, EDL) muscles by injection of local anesthetic (bupivacaine). Skeletal muscles were analyzed 10 days, 4
and 8 weeks after bupivacaine treatment. Diabetes mellitus has changed morphological properties of both slow and fast
skeletal muscles during the process of regeneration. These changes are evident in redistribution of muscle fibers and sig-
nificant level of atrophy. All fiber types of diabetic fast muscles showed stronger atrophy than muscle fibers in slow mus-
cles which have more oxidative metabolism. The changes of redistribution of muscle fibers depend on duration of diabe-
tes and affect all types of muscle fibers.
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Introduction
Streptozotocin (STZ)-induced diabetes mellitus type 1
is the most commonly used animal model for the study of
human diabetes mellitus. This model has provided useful
information about physiological and pathological chan-
ges produced in skeletal muscle by experimental diabe-
tes. Insulin is a major anabolic hormone in the body, and
its deficiency has effects on many processes and leads to
general disturbance of metabolism. The skeletal muscle
is the main site of post absorptive glucose disposal and a
major target of insulin action, both on glucose uptake
and blood flow1. The skeletal muscle is composed of a
heterogeneous population of muscle fibers which express
different myosin heavy chain (MHC) isoforms2. Four dif-
ferent types of muscle fibers with different physiological
properties can be identified using specific monoclonal an-
tibodies to MHC isoforms: slow-contracting fibers, called
type I, and three different types of fast-contracting fi-
bers, called IIA, IIX and IIB muscle fibers3,4. It has been
well documented that the skeletal muscle, the major tar-
get of insulin action, changes its histochemical and mor-
phometrical characteristics during the progression of
diabetes5–7. These effects on the skeletal muscle were
considered to be formed by a combination of neurogenic
and myogenic factors8,9. It has been demonstrated that
experimentally induced diabetes mellitus type 1 in the
rat is characterized by a considerable disturbance of
muscle protein turnover10, a decrease of protein syn-
thesis11 and an increase in protein degradation12. Skele-
tal muscle fibers have a remarkable ability to complete a
rapid and extensive regeneration13. Experimentally in-
duced skeletal muscle regeneration is a very good model
of myogenesis, which can be used to study muscle gene
expression and remodeling of the contractile apparatus
under various pathological conditions such as insulin de-
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ficiency. Induced muscle regeneration is characterized by
two phases: a degenerative phase with muscle necrosis
and a regenerative phase with muscle fiber differentia-
tion which takes place rapidly and synchronously3,14. The
aim of the present time-course study was to investigate
the influence of the diabetes mellitus type 1 on the pro-




Male Wistar rats weighing 260–310 g, two months old,
were randomly assigned to STZ-diabetic or control group,
maintained on a 12-hour dark and light schedule and fed
according to appetite with Purina rat chow. After over-
night fast, animals were anaesthetized with ether, and
streptozotocin (STZ, Zanosar, Pharmacia-UpJohn, USA)
was given by a single intraperitoneal injection (65/mg/kg).
Two days later blood glucose concentration was mea-
sured with glucose monitor (Accu-Chek II, Roche Diag-
nostic, Germany). The criterion for diagnosing an animal
as diabetic was a blood glucose concentration greater
than 16.5 mmol/L. After the diagnosis of diabetes, the re-
generation process was induced in slow (m. soleus, SOL)
and fast (m. extensor digitorum longus, EDL) skeletal
muscles by injection of local anesthetic, bupivacaine.
Blood glucose concentration and body weights of ani-
mals were recorded at least once a week. At intervals of
10 days, 4 and 8 weeks, diabetic animals and their
age-matched control animals were sacrificed by overdose
of anesthesia. Blood samples (collected into lithium-hep-
arin anticoagulant containers) were centrifuged at 4°C.
The muscles were removed and frozen in liquid nitrogen
and stored at –80°C until further analysis. Serial trans-
verse 10 mm-thick sections were cut on a cryomicrotome,
dried at room temperature and preceded for immuno-
histochemistry.
Immunohistochemistry for MHC
Transverse cryosections of SOL and EDL muscles
were stained for slow and fast myosin heavy chain iso-
forms using monoclonal antibodies specific for fiber type
I (BF-F8), IIA (SC-71), IIB (BF-F3) and for fibre type IIX
(BF-35). The antibodies were given by Prof. Stefano
Schiaffino, Department of Biomedical Sciences, Padua,
Italy. The slides were incubated at room temperature
with monoclonal antibodies (1:1000) in phosphate-buf-
fered saline (PBS) for 30 minutes. After three wash steps
in PBS, the slides were incubated for 30 minutes with
peroxidase-labelled rabbit anti-mouse IgG (Dako A/S,
Copenhagen, Denmark) in PBS (1:40). After washing in
PBS, the slides were incubated in 50 mL of diamino-
benzidine (DAB) solution (0.5M tris HCl, pH 7.6, 15 mg
of DAB, 100 mL of H2O2, 25 m of imidazol) for 20 minutes
at room temperature. The slides were dried and mounted
in Canada balsam.
Fiber typing and morphometry
The fiber type frequencies and cross sectional areas
were analyzed by the computer program for quantitative
analysis »SFORM« (VAMS, Zagreb, Croatia). One hun-
dred fibers of each type were measured by moving a pen
along the circumference of the fibers. The mean fiber
size with standard deviation (SD) was calculated. Con-
trol groups were used for comparison with denervated
muscles. Statistical evaluations were performed by Stu-
dent t-test at p<0.001 level of significance.
Statistical analysis
Data are expressed as means±SE. The differences
among experimental groups were determined by analysis
of variance, and the significance of the differences be-
tween these groups was assessed by the Student-New-
man-Keuls multiple range test.
Results
Baseline body weights, plasma glucose level and gly-
cosylated hemoglobin are summarized in Table 1. The
untreated diabetic animals exhibited a significant weight
loss during the four-week and eight-week study period.
As expected, the untreated diabetic rats had marked
hyperglycemia and elevated glycosylated hemoglobin in
respect to control animals.
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TABLE 1
BODY WEIGHT, PLASMA CONCENTRATIONS OF GLUCOSE AND GLYCOSYLATED HEMOGLOBIN (HbA1C) IN CONTROL RATS
FED REGULAR DIET AND UNTREATED DIABETIC RATS
Controls Diabetes Mellitus
10 days Week 4 Week 8 10 days Week 4 Week 8
Body weight (g) 310±14.1 370±14.1 380±56.6 285.7±39.9* 233±40.4* 249.5±37.7*
Plasma glucose
(mmol/l) 5.8±0.2 5.1±0.7 5.9±0.4 29.1±1.4* 32.3±0.9* 30.0±0.9*
HbA1C (%) 2.3±0.14 3.05±0.07 2.8±0.14 4.17±0.19* 6.17±0.06* 6.53±0.81*
Data are X±SE. * p<0.001 vs. control.
Fibre type distribution of soleus and extensor
digitorum longus muscle
The fibre type distribution of control and diabetic
SOL muscle is demonstrated in Figure 1. The soleus
muscle of control rats is a slow twitch muscle which is
composed of 87–95% fibers of type I and 5–11% fibers of
type IIA. As far as diabetic muscles are concerned, there
were no significant changes in fiber type distribution.
The most evident finding in diabetic SOL muscle was the
complete absence of type IIA fibers, i.e., in the 8th week
of muscle regeneration type I fibers became dominant.
The fibre type distribution of control and diabetic
EDL muscle is demonstrated in Figure 2. Extensor digi-
torum longus as a fast twitch muscle is composed of
6–13% fibers of type I, of 28–41% fibers of type IIA, of
0–45% fibers of type IIX and of 21–58% fibers of type IIB.
After 8 weeks of regeneration, the diabetic muscles showed
significantly higher percentage of type I and type IIA fi-
bers, which have predominant oxidative metabolism.
Fibres cross areas in soleus and extensor
digitorum longus muscle
Diabetic SOL muscles show considerable differen-
ces in fibre cross areas in respect to control muscles
(Figure 3). Fiber cross area of diabetic soleus IIA mus-
cle fibers was significantly smaller than in control
muscle at the stage of 10 days and 4 weeks of diabetes
mellitus. As shown previously, after 8 weeks of diabe-
tes type IIA fibres completely disappeared. Moreover, it
was evident that, parallel to the disappearance of type
IIA muscle fibers, the diameter of type I muscle fibers
has increased.
Diabetic EDL muscles show considerable differences
in fibre cross areas in respect to control EDL muscles
(Figure 4). In diabetic EDL muscles, the cross areas of all
fibre types were significantly smaller in respect to con-
trol muscles at all stages of the regeneration process. It is
interesting to notice that after 10 days of duration of dia-
betes there were no type IIX fibres.
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Fig. 1. Changes in fibre type distribution of rat soleus muscle in
control group (CTRL) and in groups with streptozocin induced
diabetes mellitus type 1 after the period of 10 days (DM 10 DAYS),














Fig. 2. Changes in fibre type distribution of rat extensor digito-
rum muscle (EDL) in control group (CTRL) and in groups with
streptozocin induced diabetes mellitus type 1 after the period of































Fig. 3. Fibre cross area (mm2) of rat soleus muscle in control group
(CTRL) and in diabetic animals during the period of 10 days



































Fig. 4. Fibre cross area (mm2) of rat extensor digitorum muscle in
control group (CTRL) and in diabetic animals during the period
of 10 days (DM 10 DAYS), 4 weeks (DM 4 WEEKS) and 8 weeks
(DM 8 WEEKS).
Discussion
We have investigated the process of skeletal muscle
regeneration of slow and fast muscles in streptozotocin-
-induced diabetes mellitus type 1 during the muscle re-
generation process induced by intramuscular injection of
myotoxin bupivacaine. This model of muscle regenera-
tion is characterized by inflammatory response and mono-
nuclear cell proliferation within 1–4 days of bupivacaine
injection. Myogenic cell differentiation and new myotube
formation was observed 5–6 days post injection. By day
10 the muscle architecture was restored, but myofibers
were smaller and displayed central myonuclei. The nor-
mal mature muscle was recovered at 3–4 weeks post in-
jection. All the time, the vessels, satellite cells and nerves
were intact15.
Soleus, which is mainly a slow muscle, is composed
dominantly of type I fibers and of a small percentage of
IIA muscle fibers. It is well known that diabetes induces
neuropathy, and changes in fiber type distribution can be
a response to this damage. In this study we have shown
that after 8 weeks of diabetes there were no type IIA fi-
bers. This might be an age-related alteration in muscle
tissue which is commonly seen in the process of ageing
skeletal muscle16,17. As far as fiber diameter is concerned,
it has demonstrated the reduction of IIA fiber area until
the disappearance of this fiber type. It has also shown
concomitant enlargement of type I cross-sectional area.
Diabetes mellitus type 1 has caused changes in fibre type
distribution and a significant level of atrophy of EDL
muscle. Our results have demonstrated that after 4 weeks
of diabetes, type IIX muscle fibers are predominant mus-
cle fibers, but after 8 weeks of diabetes there are more fi-
bers with oxidative metabolism (type I and IIA). The
most important and most evident finding of our study is
a strong atrophy of all muscle fibers in EDL muscle.
Skeletal muscle exhibits a high degree of plasticity, adap-
ting its phenotype expression to its metabolic profile. It
has already been shown that for example ageing and
hypoxia can change skeletal muscle phenotype18,19. The
level of atrophy of fast regenerating muscles in diabetes
mellitus is larger than in slow muscles. Our study of re-
generation capacity of fast diabetic muscles shows simi-
lar results to those previously obtained9,20,21.
Conclusion
We have found that diabetes mellitus type 1 cause the
morphological properties in both slow and fast muscles
during the muscle regeneration process. These changes
are evident in the redistribution of muscle fibers and in
the significant level of atrophy. Diabetic extensor digi-
torum longus which represents fast skeletal muscle has
shown much stronger atrophy of all muscle fibers in re-
spect to control muscles. The changes of redistribution of
muscle fibers and the degree of atrophy depend on the du-
ration of experimentally induced diabetes mellitus type 1.
The long lasting diabetes caused shift to more oxida-
tive metabolism of skeletal muscle, which is commonly
seen in the process of ageing of skeletal muscle.
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UTJECAJ EKSPERIMENTALNO IZAZVANE [E]ERNE BOLESTI TIP 1 NA REGENERACIJSKU
SPOSOBNOST SKELETNOG MI[I]A
S A @ E T A K
Mi{i}na vlakna su dinami~ne strukture sposobne mijenjati svoj fenotip u razli~itim patolo{kim stanjima. Cilj ove
studije je bio istra`iti utjecaj dugotrajne {e}erne bolesti na proces regeneracije skeletnog mi{i}a. [e}erna bolest tip 1 u
Wistar {takora izazvana je intraperitonealnom injekcijom streptozocina. U sporom (m. soleus) i brzom skeletnom mi-
{i}u (m. extensor digitorum longus) je izazvan proces regeneracije intramuskularnom injekcijom lokalnog anestetika
(bupivacain) Mi{i}i dijabeti~nih {takora analizirani su nakon 10 dana, 4 i 8 tjedana od tretmana bupivakainom. [e}erna
bolest uzrokovala je promjene morfolo{kih karakteristika kako sporog tako i brzog skeletnog mi{i}a tijekom procesa
regeneracije. Ove promjene se odra`avaju u izmjenjenoj zastupljenosti pojedinih tipova vlakana u mi{i}u kao i u zna-
~ajnom stupnju atrofije. Svi tipovi mi{i}nih vlakana u brzom skeletnom mi{i}u u {e}ernoj bolesti pokazuju ja~i stupanj
atrofije od tipova mi{i}nih vlakana u sporom mi{i}u koja imaju prete`no oksidativni metabolizam. Promjene u za-
stupljenosti pojedinih tipova vlakana u mi{i}u ovise o du`ini trajanja {e}erne bolesti i zahva}aju sve tipove mi{i}nih
vlakana, ali u mnogo ve}oj mjeri brza mi{i}na vlakna.
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